[Federal Register: May 10, 1999 (Volume 64, Number 89)]
[Notices]               
[Page 25080]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr10my99-124]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on March 2, 1999, Sigma Aldrich 
Research Biochemicals, Inc., Attn: Richard Milius, 1-3 Strathmore Road, 
Natick, Massachusetts 01760, made application by renewal to the Drug 
Enforcement Administration (DEA) for registration as a bulk 
manufacturer of the basic classes of controlled substances listed 
below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Cathinone (1235)...........................  I
Methcathionone (1237)......................  I
Aminorex (1585)............................  I
Alpha-Ethyltryptamine (7249)...............  I
Lysergic acid diethylamide (7315)..........  I
Tetrahydrocannabinols (7370)...............  I
4-Bromo-2, 5-dimethoxyamphetamine (7391)...  I
4-Bromo-2,5-dimethoxyphenethylamine (7392).  I
2, 5-Dimethoxyamphetamine (7396)...........  I
3, 4-Methylenedioxyamphetamine (7400)......  I
N-Hydroxy-3, 4-methylenedioxyamphetamine     I
 (7402).
3, 4-Methylenedioxymethamphetamine (7405)..  I
1- [1- (2-Thienyl) cyclohexyl] piperidine    I
 (7470).
Heroin (9200)..............................  I
Normorphine (9313).........................  I
Amphetamine (1100).........................  II
Methamphetamine (1105).....................  II
Phenylcyclohexylamine (7460)...............  II
Phencyclidine (7471).......................  II
Cocaine (9041).............................  II
Codeine (9050).............................  II
Diprenorphine (9058).......................  II
Benzoylecgonine (9180).....................  II
Levomethorphan (9210)......................  II
Levorphanol (9220).........................  II
Meperidine (9230)..........................  II
Metazocine (9240)..........................  II
Methadone (9250)...........................  II
Morphine (9300)............................  II
Thebaine (9333)............................  II
levo-alphacetylmethadol (9648).............  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The firm plans to manufacturer the listed controlled substances for 
laboratory reference standards and neurochemicals.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substance may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than (60 days from publication).

    Dated: April 26, 1999.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 99-11692 Filed 5-7-99; 8:45 am]
BILLING CODE 4410-09-M